Related Experiment Video
Updated: Aug 18, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Malaria resistance: artificial induction with a partially purified plasmodial fraction
Abstract:
Plasmodium berghei were released from mouse erythrocytes by passage through a French pressure cell. The released organisms were washed and disintegrated; the soluble portion was chromatographed on a Sephadex (G-200) column. The void-volume eluate contained an erythrocyte-free plasmodial fraction which behaved as a vaccine, preventing parasitemia, anemia, and death in mice subsequently challenged with living Plasmodium berghei.
Insights
Researchers developed a Plasmodium berghei vaccine from mouse red blood cells. This erythrocyte-free fraction protected mice against malaria infection, preventing disease and death.
Area of Science:
- Malariology
- Immunology
- Parasitology
Background:
- Malaria remains a significant global health challenge.
- Effective vaccines are crucial for malaria control and eradication efforts.
Purpose of the Study:
- To isolate and characterize a Plasmodium berghei fraction with potential vaccine properties.
- To evaluate the efficacy of this fraction in preventing malaria in a mouse model.
Main Methods:
- Plasmodium berghei were isolated from mouse erythrocytes using a French pressure cell.
- Isolated organisms were washed, disintegrated, and fractionated via Sephadex (G-200) chromatography.
- The void-volume eluate, an erythrocyte-free fraction, was collected for further analysis.
Main Results:
- An erythrocyte-free Plasmodium berghei fraction was successfully isolated.
- This fraction demonstrated significant vaccine-like activity in mice.
- Protected mice showed no parasitemia, anemia, or mortality upon challenge with live Plasmodium berghei.
Conclusions:
- An erythrocyte-free fraction of Plasmodium berghei possesses potent malaria vaccine potential.
- This finding opens avenues for developing novel malaria vaccines.
- Further research is warranted to explore the immunogenic components and mechanisms of this protective fraction.

